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Here we report two cases of super scans using18F-fluorodeoxyglucose positron emission tomogra-
phy (FDG-PET). A super scan was originally defined as
intense symmetrical activity in the bones and diminished
renal parenchymal activity on bone scintigraphy.1
CASE 1
A 63-year-old man presented with progressive shoulder
pain for 6 months. Right cervical and left supraclavicular
nodes were present on examination. A chest radiograph and
computed tomography (CT) showed left hilar and mediastinal
lymph node enlargement. FDG-PET revealed diffuse sym-
metrical densities throughout the skeleton (Figure 1A). Biop-
sies of the right cervical lymph node and bone marrow
demonstrated small-cell carcinoma. Small-cell lung cancer
invaded the bones and bone marrow preferentially.
CASE 2
A 48-year-old man presented with a nonproductive
cough. Chest CT revealed a mass in the left lower lobe and
left hilar lymph node swelling. FDG-PET revealed increased
uptake throughout the skeleton (Figure 1B). The transbron-
chial biopsy specimen was positive for adenocarcinoma.
To our knowledge, this is the first documentation of a
super scan detected using FDG-PET. Metastatic prostate and
breast cancers involving multiple bones or bone marrow or
systemic metabolic diseases, including hyperparathyroidism,
renal osteodystrophy, osteomalacia, hyperthyroidism, and ac-
romegaly, are reported to be causes of super scans on bone
scintigraphy.1–3 Metastasis from lung cancer rarely causes a
super scan,1 although multiple bone metastases or bone mar-
row involvement frequently occur in patients with lung can-
cer. Tumor cells in the bone marrow were documented in one
patient. Both cases had super scans due to metastatic lung
cancer because other causes were excluded clinically. PET
reveals more bone metastases than bone scintigraphy.4
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FIGURE 1. (A) Whole-body 18F-flu-
orodeoxyglucose positron emission
tomography (FDG-PET) showing dif-
fuse symmetrical densities throughout
the skeleton (case 1). (B) FDG-PET re-
vealed increased uptake throughout
the skeleton (case 2).
Journal of Thoracic Oncology • Volume 2, Number 11, November 2007 Super Scan Using PET
Copyright © 2007 by the International Association for the Study of Lung Cancer 1043
